Brookline, MA, United States of America

Janice Ann Nagy

This inventor holds 2 USPTO granted patents. Top assignee: The Beth Israel Hospital Association. Active years: 1997-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Janice Ann Nagy: Innovator in Mesothelial Cell Gene Therapy

Introduction

Janice Ann Nagy is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of gene therapy, particularly focusing on mesothelial cells. With a total of 2 patents to her name, her work is paving the way for innovative therapeutic approaches.

Latest Patents

Janice's latest patents revolve around mesothelial cell gene therapy. These patents detail methods and pharmaceutical compositions for modifying the mesothelial cells of a mammalian recipient in situ. The methods include forming a mesothelial cell expression system either in vivo or ex vivo and administering this expression system to the mammalian recipient through body cavities normally lined by mesothelial cells. This innovative approach is useful for the localized and systemic delivery of therapeutic agents in situ.

Career Highlights

Janice Ann Nagy is affiliated with The Beth Israel Hospital Association, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving therapeutic outcomes through cutting-edge gene therapy techniques.

Collaborations

Janice has collaborated with notable colleagues, including Robert William Jackman and Ty R Shockley. These partnerships enhance her research and contribute to the development of her innovative therapies.

Conclusion

Janice Ann Nagy is a trailblazer in the field of mesothelial cell gene therapy, with her patents reflecting her dedication to advancing medical science. Her contributions are vital for the future of therapeutic delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…